Probiotics and antibiotics in inflammatory bowel disease

Current Opinion in Gastroenterology

Volumn 17, Issue 4, 2001, Pages 331-335

  Gionchetti, P ^a   Rizzello, F ^a   Campieri, M ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIMYCOBACTERIAL AGENT; BACTERIAL ANTIGEN; CIPROFLOXACIN; CLARITHROMYCIN; CORTICOSTEROID; LACTIC ACID; MESALAZINE; METHYLPREDNISOLONE; METRONIDAZOLE; PROBIOTIC AGENT; RIFAXIMIN; VANCOMYCIN;

BIFIDOBACTERIUM; CLINICAL TRIAL; CROHN DISEASE; ENTERITIS; HUMAN; INTESTINE FLORA; LACTOBACILLUS; NONHUMAN; REVIEW; SACCHAROMYCES BOULARDII; STREPTOCOCCUS; ULCERATIVE COLITIS;

EID: 0034946586     PISSN: 02671379     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001574-200107000-00006     Document Type: Review

References (40)

1. Granulomatous enterocolitis induced in rats by purified bacterial cell wall fragments
2. The germfree state prevents the development of gut and joint inflammatory disease in HLA-B27 transgenic rats
3. Ulcerative colitis-like disease in mice with a disrupted interleukin-2-gene
4. Interleukin-10-deficient mice develop chronic enterocolitis
5. Tolerance exists towards residente intestinal flora but is broken in active inflammatory bowel disease (IBD)
6. Mucosal antibodies in inflammatory bowel disease are directed against intestinal bacteria
7. Early lesions of recurrent Crohn's disease caused by infusion of intestinal contents in excluded ileum
8. The role of the fecal stream in Crohn's disease: An historical and analytic perspective
9. State of the art concerning probiotic strains in milk products
10. Medical therapy for introduction and maintenace of remission in pouchitis a systematic review
11. Double blind controlled trial of oral vancomycin as adjunctive treatment in acute exacerbatio as of idiopathic colitis
12. Controlled trial of intravenous metronidazole as adjunt to corticoids in severe ulcerative colitis
13. The efficacy of tobramycin in the treatment of ulcerative colitis
14. Intravenous tobramycin and metronidazole as an adjunct to corticosteroids in acute, severe ulcerative colitis
15. Rifaximin in patients with moderate or severe ulcerative colitis refractory to steroid-treatment: A double blind, placebo-controlled trial
16. Long term treatment of ulcerative colitis with ciproflaxin: A prospective, double-blind, placebo-controlled study
17. Double blind, placebo-controlled trial of metronidazole in Crohn's disease
18. An antibiotic regimen for the treatment of active Crohn's disease: A randomized, controlled clinical trial of metronidazole plus ciprofloxacin
19. A controlled trial comparing ciprofloxacin with mesalazine for the treatment of active Crohn's disease
20. Controlled trial of metronidazole for prevention of Crohn's disease after ileal resection
21. Antibacterial therapy for Crohn's disease: A review emphasizing therapy directed against mycobacteria
22. A meta-analysis of antimycobacterial therapy for Crohn's disease
23. Open label trial of oral clarithromycin in active Crohn's disease
24. The coming age of probiotics
25. Probiotics in inflammatory bowel disease: New insight to pathogenesis or a possible therapeutic alternative?
26. The effect of exogenous administration of Lactobacillus reuteri R2LC and oat fiber on acetic-acid induced colitis in the rat
27. The effects of Lactobacillus strains and oat fiber on methotrexate-induced enterocolitis in rats
28. Lactobacillus species prevents colitis in interleukin 10 gene-deficient mice
29. Continous feeding with Lactobacillus plantarum attenuates established colitis in interleukin-10 deficient mice
30. Oral administration of antigens from intestinal flora anaerobic bacteria reduces the severity of experimental acute colitis in BALB/c mice
31. Crohn's disease and Escherichia coli: A new approach in therapy to maintain remission of colonic Crohn's disease?
32. Double-blind comparison of an oral Escherichia coli preparation and mesalazine in maintaining remission of ulcerative colitis
33. Non pathogenic Escherichia coli vs mesalazine for the treatment of ulcerative colitis: A randomised trial
34. The role of probiotic in the treatment of intestinal infections and inflammation
35. Saccharomyces boulardii in maintenance treatment of Crohn's disease
36. Probiotics in infective diarrhoea and inflamatory bowel diseases
37. Oral bacteriotherapy as maintenance treatment inpatients with chronic pouchitis: A double-blind, placebo-controlled trial
38. Prophylaxis of pouchitis onset with probiotic therapy: A double-blind placebo-controlled trial
39. Probiotics in chronic pouchitis: Restoring luminal microbial balance
40. Probiotics and inflammatory bowel disease: Is there a scientific rationale?